Comparison of 3-Factor Prothrombin Complex Concentrate and Low-Dose Recombinant Factor VIIa for Warfarin Reversal
2014 · World Journal of Emergency Surgery · 15 citations
https://doi.org/10.1186/1749-7922-9-27
S
Scott A. Chapman
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
57
Papers
855
Citations
14
h-index
18
i10-index
Scott A. Chapman is an academic researcher from University of Minnesota. The author has contributed to research in topics: Atrial Fibrillation Management and Outcomes & Venous Thromboembolism Diagnosis and Management & COVID-19 Clinical Research Studies. The author has an h-index of 14, co-authored 49 publications.
ORCID: 0000-0002-1594-1554Papers by this author
worksAngiotensin-Converting Enzyme 2 Expression and Severity of SARS-CoV-2 Infection
2023 · Microorganisms · 14 citations
https://doi.org/10.3390/microorganisms11030612
Propensity score adjusted comparison of three-factor versus four-factor prothrombin complex concentrate for emergent warfarin reversal: a retrospective cohort study
2020 · BMC Emergency Medicine · 5 citations
https://doi.org/10.1186/s12873-020-00386-z
Beyond the guidelines: original research on real-world outcomes of anticoagulation and corticosteroid in COVID-19
2025 · International Journal of Infectious Diseases · 0 citations
https://doi.org/10.1016/j.ijid.2025.107834
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat